Chronic hepatitis C healed by peginterferon-α and rivabirin treatment after kidney transplantation / 영남의대학술지
Yeungnam University Journal of Medicine
; : 150-154, 2016.
Article
in Ko
| WPRIM
| ID: wpr-78776
Responsible library:
WPRO
ABSTRACT
Hepatitis C virus (HCV) infection is present in a high proportion of patients with kidney transplantation. Compared with uninfected kidney transplant recipients, HCV infected kidney recipient have higher prevalence of liver disease and worse allograft survival after transplantation. Interferon monotherapy before transplantation is standard therapy for HCV-infected kidney transplant candidates. If HCV infection is discovered after transplantation, interferon monotherapy is considered due to the limited critical situation. However, in this patient, who was a kidney recipient, HCV infection was treated after kidney transplantation with peginterferon-α and rivabirin. As a result, the patient achieved sustained virologic response.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Ribavirin
/
Prevalence
/
Interferons
/
Kidney Transplantation
/
Hepacivirus
/
Hepatitis C, Chronic
/
Allografts
/
Transplant Recipients
/
Hepatitis, Chronic
/
Kidney
Type of study:
Prevalence_studies
Limits:
Humans
Language:
Ko
Journal:
Yeungnam University Journal of Medicine
Year:
2016
Type:
Article